Celldex Therapeutics, Inc. - Common Stock (NQ:CLDX)
Price and Volume
Detailed Quote| Volume | 175,176 |
| Open | 38.95 |
| Bid (Size) | 38.70 (100) |
| Ask (Size) | 38.81 (100) |
| Prev. Close | 39.12 |
| Today's Range | 38.70 - 40.03 |
| 52wk Range | 22.10 - 45.14 |
| Shares Outstanding | 66,344,236 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
| YTD |
+43.4%
|
+43.4%
|
| 1 Month |
-9.9%
|
-9.9%
|
| 3 Month |
+30.8%
|
+30.8%
|
| 6 Month |
+24.3%
|
+24.3%
|
| 1 Year |
+65.5%
|
+65.5%
|
More News
Read More
Celldex to Present at Upcoming Investor Conference
April 13, 2026
Via GlobeNewswire
Celldex Announces Proposed Public Offering of Common Stock
April 01, 2026
Via GlobeNewswire
Via GlobeNewswire
Via GlobeNewswire
Frequently Asked Questions
Is Celldex Therapeutics, Inc. - Common Stock publicly traded?
Yes, Celldex Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Celldex Therapeutics, Inc. - Common Stock trade on?
Celldex Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Celldex Therapeutics, Inc. - Common Stock?
The ticker symbol for Celldex Therapeutics, Inc. - Common Stock is CLDX on the Nasdaq Stock Market
What is the current price of Celldex Therapeutics, Inc. - Common Stock?
The current price of Celldex Therapeutics, Inc. - Common Stock is 38.73
When was Celldex Therapeutics, Inc. - Common Stock last traded?
The last trade of Celldex Therapeutics, Inc. - Common Stock was at 09/09/26 11:43 AM ET
What is the market capitalization of Celldex Therapeutics, Inc. - Common Stock?
The market capitalization of Celldex Therapeutics, Inc. - Common Stock is 2.57B
How many shares of Celldex Therapeutics, Inc. - Common Stock are outstanding?
Celldex Therapeutics, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>